Home > Insider Trading > Filing (0001453687-21-000076)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1453687	Selecta Biosciences Inc	SELB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055624	A Timothy Springer	36 Woodman Road Chestnut Hill MA 02467		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-24	590,000	$3.38	17,844,427	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2021-05-25	383,830	$3.55	18,228,257	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2021-05-26	926,170	$4.00	19,154,427	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	7,293,625	Direct
Common Stock	86,418	Indirect	By wife

Footnotes

The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.19 to $3.51. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Held by TAS Partners LLC. The Reporting Person is the managing member of TAS Partners LLC. The Reporting Person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.40 to $3.65. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.83 to $4.15. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.